HomePBM • NASDAQ
Psyence Biomedical Ltd
add
$5.23
0.38%
After Hours:(3.44%)-0.18
$5.05
Closed: Jul 17, 6:47:32 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 864.94K | 34.28% |
Net income | -974.43K | 96.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -863.70K | -34.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.14M | 736.78% |
Total assets | 7.32M | 546.23% |
Total liabilities | 594.37K | -95.09% |
Total equity | 6.72M | — |
Shares outstanding | 71.27K | — |
Price to book | 0.06 | — |
Return on assets | -29.55% | — |
Return on capital | -32.17% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -974.43K | 96.07% |
Cash from operations | -1.11M | -63.45% |
Cash from investing | -4.90K | -71.12% |
Cash from financing | 3.22M | 331.41% |
Net change in cash | 2.10M | 3,190.82% |
Free cash flow | -663.50K | -183.53% |
Previous close
$5.21
Day range
$5.20 - $5.60
Year range
$2.98 - $699.19
Market cap
3.73M USD
Avg Volume
48.25K
P/E ratio
0.13
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2023
Headquarters
Website
Employees
12